Acrux (ASXOpens in new window : ACR) is a pharmaceutical company dedicated to developing and commercialising topical pharmaceuticals. Incorporated in 1998 and using in house facilities and capabilities, Acrux has successfully developed and commercialised through licensees a number of topically applied pharmaceutical products in the US and Europe. Acrux is developing a range of generic products for the US market by leveraging its on-site laboratories, GMP manufacturing suite, clinical and commercial experience to bring affordable products to market. Acrux encourages collaboration and is well positioned to discuss partnering and product development.
Learn more about Acrux Learn more about our history
Acrux is listed on the Australian Securities Exchange (ASX code: ACR).
View Share Price Information View Announcements & Reports
Ross Dobinson — Non-Executive Chairman Geoff Brooke — Non-Executive Director Tim Oldham — Non-Executive Director
Michael Kotsanis — CEO & Managing Director Simon Green — Non-Executive Director
Tim Oldham — Chair, Human Capital Committee
Geoff Brooke — Chair, Audit and Risk Committee
Deborah Ambrosini — CFO & Company Secretary
103-113 Stanley Street West Melbourne VIC 3003 Australia Email: investor@acrux.com.au
Link Market Services Tower 4, 727 Collins Street, MELBOURNE VIC 3000 Locked Bag A14, Sydney South, NSW 1235
Toll-free: 1300 554 474 (Australia only) International: +61 1300 554 474 Facsimile: (02) 9287 0303 Facsimile: (02) 9287 0309 (for proxy voting)
Email: registrars@linkmarketservices.com.au Web: www.linkmarketservices.com.auOpens in new window
Pitcher Partners Level 13, 664 Collins Street, Docklands VIC 3008
Telephone: +61 3 8610 5000 Facsimile: +61 3 8610 5999 Email: info@pitcher.com.au
